Search Results - "KESARI, S"

Refine Results
  1. 1

    In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells by Jiang, P, Mukthavaram, R, Chao, Y, Nomura, N, Bharati, I S, Fogal, V, Pastorino, S, Teng, D, Cong, X, Pingle, S C, Kapoor, S, Shetty, K, Aggrawal, A, Vali, S, Abbasi, T, Chien, S, Kesari, S

    Published in British journal of cancer (14-10-2014)
    “…Background: The increasing usage of statins (the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) has revealed a number of unexpected beneficial…”
    Get full text
    Journal Article
  2. 2

    Structural investigation of borosilicate glasses containing lanthanide ions by Fabian, M., Gergely, F., Osan, J., Cendak, T., Kesari, S., Rao, R.

    Published in Scientific reports (12-05-2020)
    “…High level radioactive actinides are produced as a side product in reprocessing spent nuclear fuel, for which safe long-term-inert immobilizer matrices are…”
    Get full text
    Journal Article
  3. 3

    Bevacizumab for recurrent malignant gliomas : Efficacy, toxicity, and patterns of recurrence by NORDEN, A. D, YOUNG, G. S, KESARI, S, WEN, P. Y, SETAYESH, K, MUZIKANSKY, A, KLUFAS, R, ROSS, G. L, CIAMPA, A. S, EBBELING, L. G, LEVY, B, DRAPPATZ, J

    Published in Neurology (04-03-2008)
    “…Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor, may have activity in recurrent malignant gliomas. At recurrence some…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Determinants of survival in progressive multifocal leukoencephalopathy by MARZOCCHETTI, A, TOMPKINS, T, CLIFFORD, D. B, GANDHI, R. T, KESARI, S, BERGER, J. R, SIMPSON, D. M, PROSPERI, M, DE LUCA, A, KORALNIK, I. J

    Published in Neurology (10-11-2009)
    “…We sought to characterize the role of immunologic, virologic, and radiologic determinants of survival in patients with progressive multifocal…”
    Get full text
    Journal Article
  6. 6

    MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity by Teplyuk, Nadiya M, Mollenhauer, Brit, Gabriely, Galina, Giese, Alf, Kim, Ella, Smolsky, Michael, Kim, Ryan Y, Saria, Marlon G, Pastorino, Sandra, Kesari, Santosh, Krichevsky, Anna M

    Published in Neuro-oncology (Charlottesville, Va.) (01-06-2012)
    “…An accurate, nonsurgical diagnostic test for brain tumors is currently unavailable, and the methods of monitoring disease progression are not fully reliable…”
    Get full text
    Journal Article
  7. 7

    Improved conspicuity and delineation of high-grade primary and metastatic brain tumors using "restriction spectrum imaging": quantitative comparison with high B-value DWI and ADC by White, N S, McDonald, C R, Farid, N, Kuperman, J M, Kesari, S, Dale, A M

    Published in American journal of neuroradiology : AJNR (01-05-2013)
    “…Restriction spectrum imaging is a sensitive DWI technique for probing separable water diffusion compartments in tissues. Here, we evaluate RSI-CMs derived from…”
    Get full text
    Journal Article
  8. 8

    Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas by DOHERTY, L, GIGAS, D. C, KESARI, S, DRAPPATZ, J, KIM, R, ZIMMERMAN, J, OSTROWSKY, L, WEN, P. Y

    Published in Neurology (11-07-2006)
    “…Malignant gliomas are frequently characterized by amplification of the epidermal growth factor receptor (EGFR) and loss of PTEN tumor suppressor gene…”
    Get full text
    Journal Article
  9. 9

    An EGFR wild type–EGFRvIII–HB-EGF feed-forward loop regulates the activation of EGFRvIII by Li, L, Chakraborty, S, Yang, C-R, Hatanpaa, K J, Cipher, D J, Puliyappadamba, V T, Rehman, A, Jiwani, A J, Mickey, B, Madden, C, Raisanen, J, Burma, S, Saha, D, Wang, Z, Pingle, S C, Kesari, S, Boothman, D A, Habib, A A

    Published in Oncogene (14-08-2014)
    “…EGFRvIII is a key oncogene in glioblastoma (GBM). EGFRvIII results from an in-frame deletion in the extracellular domain of EGFR, does not bind ligand and is…”
    Get full text
    Journal Article
  10. 10

    Ultrasound-based detection of glucocorticoid-induced impairments of muscle mass and structure in Cushing’s disease by Minetto, M. A., Caresio, C., Salvi, M., D’Angelo, V., Gorji, N. E., Molinari, F., Arnaldi, G., Kesari, S., Arvat, E.

    Published in Journal of endocrinological investigation (01-07-2019)
    “…Purpose To investigate the glucocorticoid-induced impairments of muscle mass and structure in patients presenting different stages of steroid myopathy…”
    Get full text
    Journal Article
  11. 11

    bHLH Transcription factors inhibitors for cancer therapy: general features for in silico drug design by Tsigelny, I F, Kouznetsova, V L, Pingle, S C, Kesari, S

    Published in Current medicinal chemistry (01-01-2014)
    “…Numerous basic-helix-loop-helix (bHLH) transcription factors (TF) have been found to play important roles in tumor growth and progression. Elucidation of the…”
    Get more information
    Journal Article
  12. 12

    A Novel Proximity Biotinylation Assay Based on the Self-Associating Split GFP1-10/11 by Kesari, Aditi S, Aryal, Uma K, LaCount, Douglas J

    Published in Proteomes (02-12-2020)
    “…Proximity biotinylation was developed to detect physiologically relevant protein-protein interactions in living cells. In this method, the protein of interest…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Identification and development of nanoscintillators for biotechnology applications by Jung, J.Y., Hirata, G.A., Gundiah, G., Derenzo, S., Wrasidlo, W., Kesari, S., Makale, M.T., McKittrick, J.

    Published in Journal of luminescence (01-10-2014)
    “…The purpose of this work is to investigate the radioluminescence emission properties in the range 300–400nm of 15 nanoscintillators for potential application…”
    Get full text
    Journal Article
  17. 17

    Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging by McDonald, C R, White, N S, Farid, N, Lai, G, Kuperman, J M, Bartsch, H, Hagler, D J, Kesari, S, Carter, B S, Chen, C C, Dale, A M

    Published in American journal of neuroradiology : AJNR (01-06-2013)
    “…DTI is being increasingly used to visualize critical white matter tracts adjacent to brain tumors before neurosurgical resection. However, brain tumors,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Longitudinal restriction spectrum imaging is resistant to pseudoresponse in patients with high-grade gliomas treated with bevacizumab by Kothari, Pranay, White, Nathan S, Farid, Nikdokht, Chung, Romy, Kuperman, Joshua M, Girard, Holly M, Shankaranarayanan, Ajit, Kesari, Santosh, McDonald, Carrie R, Dale, Anders M

    Published in American journal of neuroradiology : AJNR (01-09-2013)
    “…Antiangiogenic therapies, such as bevacizumab, decrease contrast enhancement and FLAIR hyperintensity in patients with high-grade gliomas in a manner that may…”
    Get full text
    Journal Article
  20. 20

    Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma by Krishnan, A P, Karunamuni, R, Leyden, K M, Seibert, T M, Delfanti, R L, Kuperman, J M, Bartsch, H, Elbe, P, Srikant, A, Dale, A M, Kesari, S, Piccioni, D E, Hattangadi-Gluth, J A, Farid, N, McDonald, C R, White, N S

    Published in American journal of neuroradiology : AJNR (01-05-2017)
    “…ADC as a marker of tumor cellularity has been promising for evaluating the response to therapy in patients with glioblastoma but does not successfully stratify…”
    Get full text
    Journal Article